Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.43NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HR.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HS.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HU.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GP.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBVNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.277NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.294NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.81NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FG.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.413NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.268NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.409NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.587NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.232NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CD.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.333NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.86 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.7 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.12 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.7.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.390NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.319NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used